Brief: ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen Will Debut at Leading Wellness Clinics in August
16/07/2024 14:05
July 16 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX ANNOUNCES PHARMACEUTICAL-GRADE INTRAVENOUS AND
INJECTABLE NIAGEN® WILL DEBUT AT LEADING WELLNESS CLINICS IN
AUGUST
Source text for Eikon: ID:nBw4zfKwa
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce